8332 Federal Register / Vol. 80, No. 31 / Tuesday, February 17, 2015 / Notices 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: February 10, 2015. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03092 Filed 2–13–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Extracellular Vesicles in HIV/AIDS and 

Substance Abuse (R01, R21). 

Date: February 26, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Jagadeesh S. Rao, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, National Institutes of Health, 

DHHS, 6001 Executive Boulevard, Room 

4234, MSC 9550, Bethesda, MD 02892, 301– 

443–9511, jrao@nida.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Exploratory Studies of Smoking Cessation 

Interventions for People with Schizophrenia 

(R21/R33). 

Date: March 3, 2015. 

Time: 12:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: Jagadeesh S. Rao, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, National Institutes of Health, 

DHHS, 6001 Executive Boulevard, Room 

4234, MSC 9550, Bethesda, MD 02892, 301– 

443–9511, jrao@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; NIDA 

Core ‘‘Center of Excellence’’ Grant Program 

(P30). 

Date: March 10, 2015. 

Time: 8:30 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIAID Conference Center, 5609 

Fisher’s Lane, Rockville, MD 20852. 

Contact Person: Nadine Rogers, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, 6001 Executive 

Blvd., Room 4229, MSC 9550, Bethesda, MD 

20892–9550, 301–402–2105, rogersn2@

nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; NIDA 

Research ‘‘Center of Excellence’’ Grant 

Program (P50). 

Date: March 11, 2015. 

Time: 8:30 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIAID Conference Center, 5609 

Fisher’s Lane, Rockville, MD 20852. 

Contact Person: Nadine Rogers, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, 6001 Executive 

Blvd., Room 4229, MSC 9550, Bethesda, MD 

20892–9550, 301–402–2105, rogersn2@

nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; R13 

Conference Grant Review (PA13–347). 

Date: March 17, 2015. 

Time: 2:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Virtual 

Meeting). 

Contact Person: Minna Liang, Ph.D., 

Scientific Review Officer, Grants Review 

Branch, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, 6001 Executive Blvd., Room 4226, 

MSC 9550, Bethesda, MD 20892–9550, 301– 

435–1432, liangm@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; Loan 

Repayment 2015. 

Date: March 30, 2015. 

Time: 9:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Virtual 

Meeting). 

Contact Person: Lyle Furr, Scientific 

Review Officer, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 4227, MSC 9550, 6001 

Executive Boulevard, Bethesda, MD 20892– 

9550, (301) 435–1439, lf33c.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Interventions for Youth Who Misuse/Abuse 

Prescription Stimulant Medications in High 

School and/or College-Attending Youth 

(U01). 

Date: March 31, 2015. 

Time: 8:30 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Garden Inn Bethesda, 7301 

Waverly Street, Bethesda, MD 20814. 

Contact Person: Susan O. McGuire, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, National Institutes of Health, 

DHHS, 6001 Executive Blvd., Room 4245, 

Rockville, MD 20852, 301–435–1426, 

mcguireso@mail.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; The 

National Drug Abuse Treatment Clinical 

Trials Network (UG1). 

Date: March 31, 2015. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Contact Person: Jose F. Ruiz, Ph.D., 

Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, Room 4228, MSC 9550, 

6001 Executive Blvd., Bethesda, MD 20892– 

9550, (301) 451–3086, ruizjf@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; Avenir 

Award Program for Genetics or Epigenetics of 

Substance Abuse (DP2). 

Date: April 13, 2015. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Garden Inn Bethesda, 7301 

Waverly Street, Bethesda, MD 20814. 

Contact Person: Gerald L. McLaughlin, 

Ph.D., Scientific Review Officer, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, 6001 Executive 

Blvd., Room 4238, MSC 9550, Bethesda, MD 

20892–9550, 301–402–6626, gm145a@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos.: 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: February 9, 2015. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03095 Filed 2–13–15; 8:45 am] 

BILLING CODE 4140–01–P 


tkelley on DSK3SPTVN1PROD with NOTICES